Conflict of interest in the assessment of hyaluronic acid injections for osteoarthritis of the knee: An updated systematic review

Journal of Arthroplasty

Volumn 28, Issue 8 SUPPL, 2013, Pages 30-33.e1

  Printz, Jonathon O ^a   Lee, John J ^a   Knesek, Michael ^a   Urquhart, Andrew G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Hyaluronic acid injections; Knee osteoarthritis; Systematic review

Indexed keywords

HYALURONIC ACID; PLACEBO;

ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONFLICT OF INTEREST; DRUG INDUSTRY; FUNDING; HUMAN; INSTITUTIONAL REVIEW; KNEE OSTEOARTHRITIS; MEDICAL LITERATURE; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THERAPY EFFECT;

HYALURONIC ACID INJECTIONS; KNEE OSTEOARTHRITIS; SYSTEMATIC REVIEW;

CONFLICT OF INTEREST; DRUG INDUSTRY; GIFT GIVING; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS, KNEE; PATIENT OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84884146884     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.05.034     Document Type: Article

References (28)

1. Balazs E.A., Denlinger J.L. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 1993, 20(Suppl 39):3.
2. Peyron J.G. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 1993, 20(Suppl 39):10.
3. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003, 5(2):54.
4. Datamonitor Market Dynamics-Hyaluronic Acid Viscosupplementation 2002.
5. Altman R.D., Rosen J.E., Bloch D.A., et al. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA® for treatment of painful osteoarthritis of the knee, with an open-label safety extension (The FLEXX Trial). Semin Arthritis Rheum 2009, 39(1):1.
6. Chevalier X., Jerosch J., Goupille P., et al. Single, intra-articular treatment with 6ml Hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 2010, 69(1):113.
7. Huskisson E.C., Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999, 38(7):602.
8. Wobig M., Dickhut A., Maier R., et al. Viscosupplementation with Hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998, 20(3):410.
9. Arrich J., Piribauer F., Mad P., et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systemic review and meta-analysis. CMAJ 2005, 172(8):1039.
10. Bannuru R.R., Natov N.S., Dasi U.R., et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis. Osteoarthritis Cartilage 2011, 19(6):611.
11. Bellamy N., Campbell J., Robinson V., et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006, 2. CD005321.
12. Lo G.H., LaValley M., McAlindon T., et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003, 290(23):3115.
13. Medina J.M., Thomas A., Denegar C.R. Knee osteoarthritis: should your patient opt for hyaluronic acid injection?. J Fam Pract 2006, 55(8):669.
14. Modawal A., Ferrer M., Choi H.K., et al. Hyaluronic acid injections relieve knee pain. J Fam Pract 2005, 54(9):758.
15. Wang C.T., Lin J., Chang C.J., et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004, 86(3):538.
16. Bekelman J.E., Li Y., Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003, 289(4):454.
17. Okike K., Kocher M.S., Mehlman C.T., et al. Conflict of interest in orthopaedic research: an association between findings and funding in scientific presentations. J Bone Joint Surg Am 2007, 89(3):608.
18. Stelfox H.T., Chua G., O'Rourke K., et al. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 1998, 338(2):101.
19. Zuckerman J.D., Prasarn M., Kubiak E.N., et al. Conflict of interest in orthopaedic research. J Bone Joint Surg Am 2004, 86(2):423.
20. Bero L.A., Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care 1996, 12(2):209.
21. Callaham M.L., Wears R.L., Weber E.J., et al. Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting. JAMA 1998, 280(3):254.
22. Friedberg M., Saffran B., Stinson T.J., et al. Evaluation of conflict of interest in economic analyses of new drugs used in oncology. JAMA 1999, 282(15):1453.
23. Jang S., Chae Y.K., Haddad T., et al. Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review. Breast Cancer Res Treat 2010, 121(2):273.
24. Ancker J.S., Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 2007, 13(2):147.
25. Krimsky S., Rothenberg L.S. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 2001, 7(2):205.
26. Baker C.B., Johnsrud M.T., Crismon M.L., et al. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003, 183(Dec):498.
27. Lee Y.K., Chung C.Y., Koo K.H., et al. Conflict of interest in the assessment of thromboprophylaxis after total joint arthroplasty: a systematic review. J Bone Joint Surg Am 2012, 94(1):27.
28. Elks M.L. Conflict of interest and the physician-researcher. J Lab Clin Med 1995, 126(1):19.